title: MRI T2 characteristics in somatotroph adenomas following somatostatin analog treatment in acromegaly.
authors.affiliation: Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Rikshospitalet, Nydalen, P.b 4950, 0424, Oslo, Norway. ansgar.heck@medisin.uio.no.|Faculty of Medicine, University of Oslo, Oslo, Norway. ansgar.heck@medisin.uio.no.
authors.forename: Ansgar
authors.initials: A
authors.lastname: Heck
authors.affiliation: The Intervention Centre, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
authors.forename: Kyrre E
authors.initials: KE
authors.lastname: Emblem
authors.affiliation: Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.|Department of Pathology, Oslo University Hospital, Oslo, Norway.
authors.forename: Olivera
authors.initials: O
authors.lastname: Casar-Borota
authors.affiliation: Department of Radiology and Nuclear Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
authors.forename: Geir
authors.initials: G
authors.lastname: Ringstad
authors.affiliation: Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Rikshospitalet, Nydalen, P.b 4950, 0424, Oslo, Norway.|Faculty of Medicine, University of Oslo, Oslo, Norway.
authors.forename: Jens
authors.initials: J
authors.lastname: Bollerslev
mesh_terms: D000172:Acromegaly / Q000000981:diagnostic imaging* / Q000188:drug therapy; D000236:Adenoma / Q000000981:diagnostic imaging* / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D005260:Female; D049912:Growth Hormone-Secreting Pituitary Adenoma / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide